Monopar Therapeutics (MNPR) Return on Equity (2018 - 2025)
Quarterly results put Return on Equity at 0.0% for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was 0.0% (changed 0.0% YoY), and the annual figure for FY2024 was 0.01%, up 1.0%.
Monopar Therapeutics has reported Return on Equity over the past 8 years, most recently at 0.0% for Q4 2025.
- Return on Equity reached 0.0% in Q4 2025 per MNPR's latest filing, up from 0.0% in the prior quarter.
- Across five years, Return on Equity topped out at 0.0% in Q4 2025 and bottomed at 0.03% in Q3 2023.
- Median Return on Equity over the past 5 years was 0.01% (2022), compared with a mean of 0.01%.
- The largest annual shift saw Return on Equity fell -2bps in 2023 before it grew 2bps in 2024.
- Over 5 years, Return on Equity stood at 0.0% in 2021, then plummeted by -323bps to 0.02% in 2022, then soared by 42bps to 0.01% in 2023, then surged by 86bps to 0.0% in 2024, then soared by 62bps to 0.0% in 2025.
- Business Quant data shows Return on Equity for MNPR at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -0.04% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -0.01% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 0.00% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.00% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 0.01% |
| 10 | Monopar Therapeutics | 466.82 Mn | 466.82 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.03% |
| Jun 30, 2023 | -0.03% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 0.00% |
| Dec 31, 2019 | -0.01% |
| Sep 30, 2019 | -0.01% |
| Jun 30, 2019 | -0.01% |
| Mar 31, 2019 | -0.01% |
| Dec 31, 2018 | 0.00% |
| Sep 30, 2018 | 0.00% |
| Jun 30, 2018 | -0.02% |
| Mar 31, 2018 | -0.02% |